EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

One‐carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study

Maki Inoue-Choi iD, Neal D Freedman, Arash Etemadi iD, Maryam Hashemian, Paul Brennan iD, Gholamreza Roshandel iD, Hossein Poustchi, Paolo Boffetta iD, Farin Kamangar, Taghi Amiriani, Alireza Norouzi, Sandy Dawsey und 2 weitere

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35115 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Maki Inoue-Choi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Stomach Neoplasms, Esophageal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Agency for Research on Cancer, Intramural NIH HHS, National Cancer Institute, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Incidence of esophageal and gastric cancer has been linked to low B‐vitamin status. We conducted matched nested case–control studies of incident esophageal squamous cell carcinoma (ESCC; 340 case–control pairs) and gastric cancer (GC; 352 case–control pairs) within the Golestan Cohort Study. The primary exposure was plasma biomarkers: riboflavin and flavin mononucleotide (FMN) (vitamin B2), pyridoxal phosphate (PLP) (B6), cobalamin (B12), para‐aminobenzoylglutamate (pABG) (folate), and total homocysteine (tHcy); and indicators for deficiency: 3‐hydroxykyurenine‐ratio (HK‐r for vitamin B6) and methylmalonic acid (MMA for B12). We estimated odds ratios (ORs) and 95% confidence intervals (CIs) using conditional logistic regression adjusting for matching factors and potential confounders. High proportions of participants had low B‐vitamin and high tHcy levels. None of the measured vitamin B levels was associated with the risk of ESCC and GC, but elevated level of MMA was marginally associated with ESCC (OR = 1.42, 95% CI = 0.99–2.04) and associated with GC (OR = 1.53, 95% CI = 1.05–2.22). Risk of GC was higher for the highest versus lowest quartile of HK‐r (OR = 1.95, 95%CI = 1.19–3.21) and for elevated versus non‐elevated HK‐r level (OR = 1.59, 95% CI = 1.13–2.25). Risk of ESCC (OR = 2.81, 95% CI = 1.54–5.13) and gastric cancer (OR = 2.09, 95%CI = 1.17–3.73) was higher for the highest versus lowest quartile of tHcy. In conclusion, insufficient vitamin B12 was associated with higher risk of ESCC and GC, and insufficient vitamin B6 status was associated with higher risk of GC in this population with prevalent low plasma B‐vitamin status. Higher level of tHcy, a global indicator of OCM function, was associated with higher risk of ESCC and GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsEsophageal NeoplasmsHumansMaleMiddle AgedFemaleCase-Control StudiesCohort StudiesAgedBiomarkers, TumorCarcinoma, Squamous CellVitamin B 12Esophageal Squamous Cell CarcinomaCarbonHomocysteineAdultFolic AcidMethylmalonic AcidRiboflavin

Stichwörter der Autor:innen

biomarkersesophageal cancergastric cancerone‐carbon metabolismvitamin B

Substanzen

Biomarkers, TumorVitamin B 12CarbonHomocysteineFolic AcidMethylmalonic AcidRiboflavin

Autor:innen und Institutionen

  • Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Epidemiology and Community Health Branch, Division of Intramural Research, National Heart, Lung, Blood Institute, Bethesda, Maryland, USA.
  • Genetic Section, Genomic Epidemiology, International Agency for Research on Cancer, Lyon, France.
  • Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Golestan, Iran.
  • Department of Family, Population and Preventive Medicine, Stony Brook University, Stony Brook, New York; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, Maryland, USA.

ORCID-Profile: Maki Inoue-Choi, Arash Etemadi, Paul Brennan, Gholamreza Roshandel, Paolo Boffetta

Förderung

  • International Agency for Research on Cancer
  • Intramural NIH HHS
  • National Cancer Institute, National Institutes of Health
  • Tehran University of Medical Sciences and Health Services
  • World Health Organization
  • Centre International de Recherche sur le Cancer

Zitieren

APA

Inoue-Choi, M., Freedman, N. D., Etemadi, A., Hashemian, M., Brennan, P., Roshandel, G., Poustchi, H., Boffetta, P., Kamangar, F., Amiriani, T., Norouzi, A., Dawsey, S., Malekzadeh, R., & Abnet, C. C. (2024). One‐carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study. International Journal of Cancer. https://doi.org/10.1002/ijc.35115

Vancouver

Inoue-Choi M, Freedman ND, Etemadi A, Hashemian M, Brennan P, Roshandel G, et al. One‐carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study. International Journal of Cancer. 2024. doi:10.1002/ijc.35115

BibTeX
@article{InoueChoi2024,
  author = {Inoue-Choi, Maki and Freedman, Neal D and Etemadi, Arash and Hashemian, Maryam and Brennan, Paul and Roshandel, Gholamreza and Poustchi, Hossein and Boffetta, Paolo and Kamangar, Farin and Amiriani, Taghi and Norouzi, Alireza and Dawsey, Sandy and Malekzadeh, Reza and Abnet, Christian C},
  title = {One‐carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35115}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche